SaNOtize Ramps Up Anti-COVID Nasal Spray Production To Keep Up With Demand
SaNOtize is increasing production in Israel and beyond as it attempts to keep up with international demand for its Enovid nasal spray.
November 30, 2021
SaNOtize To Launch UK Clinical Trial For Anti-COVID Nasal Spray
The Nitric Oxide Nasal Spray developed by SaNOtize is designed to kill the virus in the upper airways, preventing it from reaching the lungs.
January 10, 2021
SaNOtize To Begin Phase II Trial For Potential COVID-19 Therapy
The Vancouver-based company, co-founded by an Israeli scientist, developed a patented platform for the topical delivery of nitric oxide to treat a variety of bacterial, fungal, and viral diseases.
April 26, 2020